Smoking and Its Effect on CEA Concentration

Introduction

CEA is a particular blood protein measured by a carcinoembryonic antigen (CEA) test. People often have high CEA levels at birth, which fall with age. However, this protein can rise in certain cancer forms. A glycoprotein involved in cell adhesion called carcinoembryonic antigen (CEA) is frequently tested in blood tests as a tumor marker, particularly for colorectal cancer. Increased CEA levels have been linked to several cancers, including lung, pancreatic, colon, and rectum tumors. In addition to cancer, other illnesses like inflammation, infections, and chronic illnesses can also raise CEA levels. Interestingly, it has been noted that smoking affects CEA concentrations. The relationship between smoking and CEA levels is examined in this article, along with the mechanisms underlying it and its practical consequences for clinical settings.

What Is CEA and in Which Cancers Is It Elevated?

The intricate protein CEA is involved in signaling and cellular interactions. Its naming stems from its initial discovery in human colon cancer tissue extracts and its later identification in embryonic digestive system tissues. CEA levels are used in clinical practice to track how well cancer patients are responding to treatment and to look for cancer recurrence after surgery. In non-smokers, normal CEA levels are typically less than three ng/mL (nanograms per milliliter), while in smokers, they are slightly higher.

Cancers that may have elevated CEA levels include:

• Colorectal cancer.

• Pancreas cancer.

• Stomach cancer.

• Thyroid cancer.

• Bladder cancer.

• Cancer of the ovaries.

• Breast cancer.

• Cancer of the lung.

• Leukemia.

• Cancer of the lymph nodes.

What Are the Reasons for Smokers Elevated CEA Levels?

Smokers had a mean level of CEA that was greater than that of nonsmokers (9.19 vs. 2.15 ng/ml), and it was also shown that the number of cigarettes smoked each day raised the level of CEA. The amount of the tumor-associated antigen CEA varies amongst patients who have had varying amounts of smoking exposure.

There is ample evidence to support the association between smoking and elevated CEA levels. This connection could be explained by several mechanisms:

• Tobacco Carcinogens: A variety of carcinogens, including nitrosamines and polycyclic aromatic hydrocarbons, are found in cigarette smoke and can cause cellular damage as well as an inflammatory response. CEA may be released from both malignant and non-cancerous tissues as a result of this inflammation.

• Chronic Inflammation: Smoking irritates the respiratory system over time. Because persistent inflammation and tissue damage are a prevalent feature of chronic bronchitis and chronic obstructive pulmonary disease (COPD), smokers are also more likely to have increased CEA levels.

• Oxidative Stress: Smoking causes oxidative stress, which in turn causes reactive oxygen species (ROS) to be released. ROS can damage lipids, proteins, and DNA (deoxyribonucleic acid, which carries genetic information) in cells, which may cause those cells to leak CEA.

• Modulation of the Immunological Response: Smoking has an impact on the immunological system, which results in changes in immune cell activity and cytokine production. The expression and release of CEA may be improved by this modification.

What Are the Clinical Consequences of Elevated CEA Levels?

Significant clinical ramifications result from smokers' elevated CEA levels, especially when it comes to cancer diagnosis and surveillance, include:

• Diagnostic Accuracy: When employing CEA as a tumor marker, elevated baseline levels in smokers may provide false-positive results. When evaluating CEA values, doctors must take the patient's smoking status into account to prevent needless diagnostic tests or concerns for the patient.

• Monitoring and Surveillance: It is critical to differentiate between tumor activity-induced rise of CEA and smoking-related elevation in smokers with cancer, especially lung cancer. Clinical judgments can be made with more accuracy with the support of routine monitoring and a thorough awareness of the patient's smoking history.

• Risk Stratification: It is important to stress quitting smoking not only for overall health reasons but also to increase CEA's specificity as a tumor marker. The reliability of CEA tests may be improved by the fact that former smokers typically have lower CEA levels than current smokers.

• Public Health Messaging: As part of broader anti-smoking messages, public health campaigns can draw attention to the effect smoking has on CEA levels. People may be more inclined to give up smoking if they are made aware of the possibility that smoking could obstruct crucial medical testing.

What Are the Methods to Reduce Elevated CEA Levels?

However, treating the ailment could also return the protein release to normal if the elevated CEA is caused by illnesses other than cancer. The following activities can also assist in naturally lowering CEA levels and promoting well-being.

• Handling Stress: Stress has been linked for a long time to tumor growth and elevated CEA levels. In addition to receiving treatment, learn stress-reduction strategies like mindful breathing, meditation, and other activities that help the de-stress.

• Give up Smoking: Research indicates that smokers have higher CEA levels than non-smokers. This may be brought on by long-term inflammation of the lung cells by repeated tobacco exposure. Consequently, one should stop smoking or abstain from it completely if a blood test reveals increased CEA.

• Frequent Exercise: A 2014 clinical investigation recommended exercise as a useful strategy to lower CEA expression. It is advised to engage in light to moderate exercise two or three times a week. It is critical to realize that intense exercise, particularly for cancer patients, may negate the health benefits of physical activity.

• Boost Vitamin D: The treatment's CEA-lowering mechanism can be supplemented by making sure they get enough vitamin D throughout. Take some time to bask in the sun outside, preferably first thing in the morning. They can also add foods like salmon, oranges, egg yolks, fortified meals, and salmon to their diet to assist the body in generating vitamin D. If their doctor believes they are vitamin insufficient, they can be recommended to have a blood test for vitamin D deficiency.

• Consuming Meals Rich in Omega-3 Fatty Acids: Omega-3 fatty acids, like vitamin D, can inhibit CEA. By gravitating toward foods like fish (mackerel, sardines, herring, salmon), seafood, and seeds like chia and flax seeds, they may add this important nutrient to their diet.

The doctor should provide individuals with appropriate treatment and guidance if they have elevated CEA due to malignant tumors. See the physician before implementing any of the above actionable advice, especially the ones that deal with supplementation.

Conclusion

By primarily utilizing pathways involving tobacco carcinogens, chronic inflammation, oxidative stress, and immune response regulation, smoking dramatically raises the levels of CEA in the blood. Regarding the application of CEA as a tumor marker, this association has significant therapeutic ramifications. Comprehending how smoking affects CEA levels can help with monitoring procedures, increase diagnostic precision, and promote public health campaigns that lower the incidence of smoking. When evaluating CEA values, clinicians need to consider smoking status to give patients appropriate and efficient therapy. By doing this, they will be able to differentiate between elevations that are benign and those that are suggestive of cancer, which will ultimately improve patient outcomes and enable more accurate medical treatment.